Opko Health (OPK) PT Trimmed at Jefferies Post Q2, 'Buy' Maintained

Go back to Opko Health (OPK) PT Trimmed at Jefferies Post Q2, 'Buy' Maintained

Opko Health (OPK) Tops Q2 EPS by 3c

August 11, 2014 4:49 PM EDT

Opko Health (NYSE: OPK) reported Q2 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $23.5 million versus the consensus estimate of $23.7 million.

"In the second quarter, we continued to make strides in converting our advanced pipeline of diagnostic and... More